Company News

DSM in Talks to Acquire Adare Biome

The enterprise value is $342 million.

Author Image

By: Lianna Albrizio

Associate Editor

Royal DSM, a global science-based leader in health, nutrition and bioscience, has entered into exclusive negotiations with Adare Pharma Solutions to acquire Adare Biome, a pioneer in the development and manufacturing of postbiotics.   The enterprise value is $342 million, according to a press release on the company website.   Postbiotics is a rapidly emerging segment of the gut health market with strong projected growth. Unlike the live bacteria in probiotics, postbiotics consist...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters